pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
ACADIA PHARMACEUTICALS INC ($ACAD) · news · pharmadog
← back to ACADIA PHARMACEUTICALS INC
News mentioning $ACAD
9
stories
9d
Novo pursues long-acting obesity drugs; Acadia slumps on Alzheimer’s data
biopharma dive
10d
Acadia drug fails mid-stage study in Alzheimer's psychosis, leading to modified Phase 3
endpoints
10d
Acadia slides on Phase 2 miss in Alzheimer’s psychosis but keeps moving asset forward
biospace
11d
Acadia misses mark in Alzheimer’s but concludes phase 3 ‘absolutely worth’ pursuing
fiercebiotech
Sep 3, 26
An AI drug specialist zeroes in on rare forms of obesity
biopharma dive
Jun 26, 26
On second try, Acadia drug gets nod from European regulators
biopharma dive
Jun 15, 26
Celiac disease is entering a new era of therapeutic innovation
biopharma dive
Jun 12, 26
Rapport ‘fully prepared’ to launch seizure drug solo, CEO says
biopharma dive
May 7, 26
Reigniting Your Curiosity During Fellowship
onclive
